Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome

Phase 2 Completed 132 enrolled Takeda

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the ability of ramelteon, once daily (QD), to advance the timing of sleep in individuals with delayed sleep phase syndrome.

Timeline

Start: 2007-10
Primary completion: 2008-05
Completion: 2008-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramelteon	Unknown	1 mg	Oral
Subject	Ramelteon	Unknown	4 mg	Oral
Subject	Ramelteon	Unknown	8 mg	Oral

Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome

Summary

Timeline

Drugs

Indications